KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,874,000 | -76.1% | 65,000 | -88.9% | 0.01% | -72.0% |
| Q4 2014 | $20,365,000 | -11.2% | 587,226 | -16.1% | 0.05% | -12.3% |
| Q3 2014 | $22,932,000 | -14.6% | 700,000 | 0.0% | 0.06% | -17.4% |
| Q2 2014 | $26,859,000 | -14.9% | 700,000 | -11.9% | 0.07% | -19.8% |
| Q1 2014 | $31,577,000 | -20.9% | 794,200 | -25.7% | 0.09% | -18.9% |
| Q4 2013 | $39,905,000 | +75.1% | 1,068,400 | +113.7% | 0.11% | +60.6% |
| Q3 2013 | $22,795,000 | +98.3% | 500,000 | +17.6% | 0.07% | +88.6% |
| Q2 2013 | $11,496,000 | +11.0% | 425,000 | 0.0% | 0.04% | +2.9% |
| Q1 2013 | $10,353,000 | – | 425,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |